Literature DB >> 6885162

Fungistatic mechanism of human transferrin for Rhizopus oryzae and Trichophyton mentagrophytes: alternative to simple iron deprivation.

W M Artis, E Patrusky, F Rastinejad, R L Duncan.   

Abstract

Human serum, human transferrin (TF), and the iron chelator 1,10-phenanthroline (OP) produce iron-reversible fungistatic activity which has been attributed to simple iron deprivation. In this study, the influence of the size of the inoculum on the inhibitory activity of serum, TF, and OP prepared with the same iron-binding capacity (2.5 micrograms/ml) for Rhizopus oryzae and Trichophyton mentagrophytes was examined. Inhibition was monitored in liquid microcultures maintained at 37 degrees C and pH 7.4 to 7.5 by measuring the change in absorbance density. Increasing the number of spores in the inoculum disrupted the fungistatic activity of serum and TF, but not that of OP. The dilution at which OP lost fungistatic activity was not affected by the number of spores in the inoculum and was the same for both fungi. The dilution at which TF and serum lost fungistatic activity was dependent upon both the quantity of the inoculum and the species of fungus. The number of viable spores, rather than the total number of spores in the inoculum, was determined to be important in overcoming the inhibition of fungal growth by serum and TF. The fungistatic activity of serum and TF could be diminished by the preexposure of the serum to viable but nongrowing spores. Direct and indirect fluorescence studies indicated that both T. mentagrophytes and R. oryzae absorbed TF. Glucose uptake by R. oryzae was inhibited by a 4-h exposure to 5.0 to 0.15 mg of apotransferrin per ml. These results suggest that the fungistatic activity of TF for R. oryzae and T. mentagrophytes may not be attributable to simple iron deprivation and raise the possibility of a requirement for a direct interaction.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6885162      PMCID: PMC264635          DOI: 10.1128/iai.41.3.1269-1278.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Transferrin, iron, and dermatophytes. I. Serum dematophyte inhibitory component definitively identified as unsaturated transferrin.

Authors:  R D King; H A Khan; J C Foye; J H Greenberg; H E Jones
Journal:  J Lab Clin Med       Date:  1975-08

2.  Ambivalent effect of protein binding on computed distributions of metal ions complexed by ligands in blood plasma.

Authors:  P M May; P W Linder; D R Williams
Journal:  Experientia       Date:  1976-12-15

3.  The detection of four molecular forms of human transferrin during the iron binding process.

Authors:  D G Makey; U S Seal
Journal:  Biochim Biophys Acta       Date:  1976-11-26

Review 4.  Iron and infection.

Authors:  E D Weinberg
Journal:  Microbiol Rev       Date:  1978-03

Review 5.  Iron and susceptibility to infectious disease.

Authors:  E D Weinberg
Journal:  Science       Date:  1974-05-31       Impact factor: 47.728

6.  The effects of structural modifications on the biologic activity of human transferrin.

Authors:  S Kornfeld
Journal:  Biochemistry       Date:  1968-03       Impact factor: 3.162

7.  The structure of a phytohemagglutinin receptor site from human erythrocytes.

Authors:  R Kornfeld; S Kornfeld
Journal:  J Biol Chem       Date:  1970-05-25       Impact factor: 5.157

8.  The relationship of transferrin and iron to serum inhibition of Candida albicans.

Authors:  N B Esterly; S R Brammer; R G Crounse
Journal:  J Invest Dermatol       Date:  1967-11       Impact factor: 8.551

9.  Antifungal activity of transferrin.

Authors:  A Shiraishi; T Arai
Journal:  Sabouraudia       Date:  1979-03

10.  Enterochelin (enterobactin): virulence factor for Salmonella typhimurium.

Authors:  R J Yancey; S A Breeding; C E Lankford
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

View more
  10 in total

Review 1.  Host-parasite interaction in fungal infections.

Authors:  N Khardori
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

2.  Future directions in mucormycosis research.

Authors:  Dimitrios P Kontoyiannis; Russell E Lewis; Oliver Lortholary; Oliver Lotholary; Brad Spellberg; Georgios Petrikkos; Emmanuel Roilides; Emmanuel Roillides; Ashraf Ibrahim; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

3.  Experimental candidiasis in liver injury.

Authors:  F Abe; S Nagata; M Hotchi
Journal:  Mycopathologia       Date:  1987-10       Impact factor: 2.574

4.  Effects of endotoxin (lipopolysaccharides) on experimental aspergillosis in leukemic mice.

Authors:  F Abe; T Katoh; T Kaneko; M Hotchi
Journal:  Mycopathologia       Date:  1987-08       Impact factor: 2.574

5.  Interaction of lactoferrin with Escherichia coli cells and correlation with antibacterial activity.

Authors:  P Visca; C Dalmastri; D Verzili; G Antonini; E Chiancone; P Valenti
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

Review 6.  Immunology of diseases associated with Malassezia species.

Authors:  H Ruth Ashbee; E Glyn V Evans
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

7.  Iron metabolism and fungal infections in patients with haematological malignancies.

Authors:  C Iglesias-Osma; L Gonzalez-Villaron; J F San Miguel; M D Caballero; L Vazquez; S de Castro
Journal:  J Clin Pathol       Date:  1995-03       Impact factor: 3.411

8.  Monitoring of filamentous fungal growth by in situ microspectrophotometry, fragmented mycelium absorbance density, and 14C incorporation: alternatives to mycelial dry weight.

Authors:  T C Granade; M F Hehmann; W M Artis
Journal:  Appl Environ Microbiol       Date:  1985-01       Impact factor: 4.792

9.  Experimental candidiasis associated with liver injury. Role of transferrin.

Authors:  F Abe; T Katoh; H Inaba; M Hotchi
Journal:  Mycopathologia       Date:  1988-10       Impact factor: 2.574

Review 10.  Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic.

Authors:  Ayushi Sharma; Anjana Goel
Journal:  Folia Microbiol (Praha)       Date:  2022-02-26       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.